Aspiriant LLC’s TCW Transform Systems ETF PWRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Buy
160,006
+12,927
+9% +$1.32M 0.45% 33
2025
Q4
$14.1M Buy
147,079
+4,296
+3% +$422K 0.41% 36
2025
Q3
$13.9M Buy
142,783
+1,268
+0.9% +$118K 0.43% 36
2025
Q2
$12.8M Buy
141,515
+2,920
+2% +$225K 0.41% 36
2025
Q1
$9.67M Buy
138,595
+7,108
+5% +$538K 0.34% 37
2024
Q4
$9.54M Buy
131,487
+104,137
+381% +$7.83M 0.34% 38
2024
Q3
$2.02M Buy
+27,350
New +$1.89M 0.08% 95

Other funds holding PWRD

Aspiriant LLC's PWRD Position: Q1 2026 in Review

Aspiriant LLC increased its TCW Transform Systems ETF (PWRD) stake by 8.8% in Q1 2026, buying an estimated $1.32M and bringing the position to 160,006 shares worth $15.6M. The position accounts for 0.45% of the portfolio, ranked #33.

Aspiriant LLC first reported a position in PWRD in Q3 2024 and has held it in 7 quarters since. 124 funds tracked by Wall St. Rank hold PWRD as of Q1 2026.

  • Aspiriant LLC held 160,006 shares of TCW Transform Systems ETF worth $15.6M as of Q1 2026.
  • Aspiriant LLC bought 12,927 TCW Transform Systems ETF shares in Q1 2026, an estimated $1.32M.
  • TCW Transform Systems ETF made up 0.45% of Aspiriant LLC's portfolio in Q1 2026, its #33 holding.
  • Aspiriant LLC first reported a position in TCW Transform Systems ETF in Q3 2024 and has held it in 7 quarters since.
  • 124 funds tracked by Wall St. Rank held TCW Transform Systems ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.